Laura Wilson
Acute Care · El Paso, TXNPI 1477984615
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $25,140 of the $31,685 with a category attached, or 79.3%. Medtronic accounts for 63.6% of it on its own, with 17 other manufacturers making up the rest. Among acute care clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 584 payments — averaging $54.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$20K
- Abbott$3K
- Shockwave Medical, Inc$2K
- Abiomed$2K
- Inari Medical, Inc.$1K
- Edwards Lifesciences$1K
- plus $2K from 12 others
What the payments were for
- Travel & lodging$6,43720%
- Food & beverage$25,14079%
- Education$1080%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 309 | $20,152 |
| Abbott | 58 | $3,093 |
| Shockwave Medical, Inc | 42 | $1,876 |
| Abiomed | 47 | $1,700 |
| Inari Medical, Inc. | 22 | $1,372 |
| Edwards Lifesciences | 12 | $1,064 |
| Novartis | 35 | $553 |
| AstraZeneca | 14 | $453 |
| Boston Scientific | 15 | $399 |
| Penumbra, Inc. | 3 | $238 |
| Chiesi USA, Inc. | 7 | $189 |
| Heartflow, Inc. | 1 | $144 |
| Cvrx, Inc. | 3 | $142 |
| Boehringer Ingelheim | 5 | $100 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $86 |
| Bard Peripheral Vascular, Inc. | 5 | $83 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$3,684
- Micra$2,027
- CARDIOMEMS$614
- FLOWTRIEVER CATHETER, S$549
- CT THROMBECTOMY SYSTEM KIT$549
- Edwards SAPIEN 3 Transcatheter Heart Valve$446
- RESOLUTE ONYX$367
- SYMPLICITY G3$365
- CoreValve Evolut$349
- MitraClip System$345
- ONYX FRONTIER$263
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$256
- 3F$236
- Merlin Connectivity and Remote$197
- SAPIEN 3 Ultra RESILIA$175
- FFRct$144
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$130
- MyCareLink$126
- Impella$125
- BRILINTA$125
How this compares
$31,685 in reported general payments places this provider in the 95th percentile of 2,323 acute care providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 53 | $28,097 |
| FarxigaDapagliflozin Propanediol | 39 | $27,927 |
| EliquisApixaban | 25 | $20,841 |
| EntrestoSacubitril/Valsartan | 19 | $13,019 |
| Ranolazine ErRanolazine | 13 | $959 |
| Atorvastatin Calcium | 62 | $630 |
| ClopidogrelClopidogrel Bisulfate | 88 | $608 |
| Metoprolol Succinate | 52 | $582 |
| Prasugrel Hcl | 14 | $565 |
| Losartan Potassium | 45 | $510 |
| Rosuvastatin Calcium | 35 | $409 |
| Amiodarone Hcl | 20 | $232 |
| Spironolactone | 41 | $214 |
| Amlodipine Besylate | 26 | $145 |
| Cephalexin | 27 | $143 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta, Farxiga | $453 | $56,02592 claims |
| NovartisEntresto | $553 | $13,01919 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,323 acute care providers in Texas.
Other acute care in El Paso
- Ahtesham AliEl Paso$14K
- Adriana SanchezEl Paso$11K
- Haydee BirkhimerEl Paso$10K
- Patricia DandEl Paso$9K
- Dora CarcobaEl Paso$8K
- Jennifer PilotteDallas$232K
- Christie MorrisonSan Antonio$225K
- Amanda BradleyDallas$85K
- Kim HuynhCypress$29K
- Martha LibertyDallas$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.